Manufacturing limits spark fears of COVID-19 vaccine nationalism

There is broad agreement on the importance of creating policies to determine which countries will receive COVID-19 vaccines, but little concurrence on what those policies should be or how they will be created.

On Wednesday, pharmaceutical company executives, former senior U.S. government officials and the leader of an academic COVID-19 vaccine development collaboration presented differing views on what will and should happen. ...